Patient social function and quality of life in schizophrenia: focus on paliperidone palmitate

Abstract

The long-term outcomes of treatment with new selective antipsychotic for patients with schizophrenia have been discussed. Using the example of patients treated with “Xeplion” for secondary prevention of worsening symptoms of the disorder and changing in patient social functionality are in the focus. Especial attention paid on safety and efficacy of the treatment. Addressed to psychiatrists working in health services and researchers.

Keywords

• антипсихотическая терапия
• атипичные антипсихотики
• палиперидона пальмитат
• социальное функционирование больных
• качество жизни
• pharmacotherapy of schizophrenia
• atypical antipsychotics
• paliperidone palmitate
• patient social function
• anti-relapse treatment quality of life